Biotech · Private company · San Jose, CA, US
Neovascularx, Inc
Track this companyFree. Adds Neovascularx, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Topical Ophthalmic Treatment for Neovascular Age-related Macular Degeneration (nAMD)Fiscal year 2025 · $305.3KNIH RePORTER 1R43EY038159-01 · fetched Nov 12, 2026